SNANF (Sona Nanotech) Cash-to-Debt : 3.54 (As of Jan. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Sona Nanotech's cash to debt ratio for the quarter that ended in Jan. 2025 was 3.54.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Sona Nanotech could pay off its debt using the cash in hand for the quarter that ended in Jan. 2025.

The historical rank and industry rank for Sona Nanotech's Cash-to-Debt or its related term are showing as below:

SNANF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07 Med: 0.5 Max: 4.71
Current: 4.71

During the past 13 years, Sona Nanotech's highest Cash to Debt Ratio was 4.71. The lowest was 0.07. And the median was 0.50.

SNANF's Cash-to-Debt is ranked better than
68.02% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.22 vs SNANF: 4.71

Sona Nanotech Cash-to-Debt Historical Data

The historical data trend for Sona Nanotech's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Sona Nanotech Cash-to-Debt Chart

Sona Nanotech Annual Data

Trend

Oct14

Oct15

Oct16

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Cash-to-Debt

Get a 7-Day Free Trial

0.07

0.90

0.27

0.22

4.71

Sona Nanotech Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Cash-to-Debt	Get a 7-Day Free Trial															0.28	0.06	0.04	4.71	3.54

Competitive Comparison of Sona Nanotech's Cash-to-Debt

For the Diagnostics & Research subindustry, Sona Nanotech's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sona Nanotech's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Sona Nanotech Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Sona Nanotech's Cash to Debt Ratio for the fiscal year that ended in Oct. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.351	/	(0	+	0.287)
	=	4.71

Sona Nanotech's Cash to Debt Ratio for the quarter that ended in Jan. 2025 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.006	/	(0	+	0.284)
	=	3.54

Sona Nanotech (OTCPK:SNANF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Sona Nanotech Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sona Nanotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (OTCPK:SNANF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

SONA:Canada

Address

1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7

Website

https://www.sonanano.com

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.